section name header

Use and Dosing

Adult Dosingnavigator.gif

Multiple Myeloma

Erythema nodosum leprosum

HIV associated wasting (Not FDA approved)

Recurrent Aphthous Stomatitis (Not FDA approved)

Crohn's disease, refractory (Not FDA approved)

Graft-versus-host disease (Not FDA approved)

Pediatric Dosingnavigator.gif

Erythema Nodosum Leprosum

Children >12 yrs


[Outline]

Indications

Contraindications

Notes

Black Box Warnings

Dosing Adjustment

Renal Dose Adjustment

Hepatic Dose Adjustment

Warnings/Precautions

Cautions: Use cautiously in

Pregnancy/Breast Feeding

Pregnancy Category:X

Breastfeeding: Unsafe, because of the potential for serious adverse reactions in nursing infants, a decision should be made for the discontinuation of nursing or the discontinuation of drug (taking into account the importance of the drug to the mother)

Adverse Reactions

Clinical Pharmacology

Brands and Availability

flag_usa32.png

US Trade Name(s)

US Availability

Thalomid

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

Thalomid

flag_uk32.png

UK Trade Name(s)

UK Availability

thalidomide (generic)

flag_australia32.png

Australian Trade Name(s)

Australian Availability

thalidomide (generic)

Thalomid


[Outline]

flag_usa32.pngflag_canada32.pngflag_uk32.pngflag_australia32.png

Classification

Hematology/Oncology

Immunomodulator

Pill